🇺🇸 OGN — Organon & Co.

Salud Mantener
← Volver

Precio actual

13,85 USD

Máx. histórico

39,36

1707 días

Caída desde máximo

-64,81%

Rango 52 semanas

5,69 – 13,85

Variación hoy

+0,22%

Cierre anterior

13,82

Rango de hoy

13,83 – 13,85

Volumen hoy

3.657.869

Peor caída histórica

-82,69%

02/03/2022 → 30/03/2026

Aún sin recuperar

Volatilidad anualizada ⓘ

46,97%

Información
Nombre completo
Organon & Co.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
10.000
PER ⓘ
17,76 (puede no estar actualizado)
Dividend yield
0,58% (puede no estar actualizado)
Precio objetivo analistas
10,33 USD (puede no estar actualizado)
Primera cotización
14/05/2021
Precio actualizado
hace 18 horas
Sobre la empresa

Organon & Co. develops and delivers women health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, China, Latin America, the Middle East, Russia, Africa, and internationally. The company's women's health portfolio comprises contraception and fertility brands, such as Nexplanon, a long-acting reversible contraceptive; NuvaRing, a monthly vaginal contraceptive ring; Cerazette, Marvelon, and Mercilon to prevent pregnancy; Follistim AQ, which is used to promote development of ovarian follicles; Elonva, a follicle stimulant; Ganirelix acetate injection, an injectable antagonist; Jada for abnormal postpartum uterine bleeding and hemorrhage; and Xaciato for bacterial vaginosis. Its biosimilars portfolio consists of immunology products, such as Brenzys, Renflexis, and Hadlima; oncology products, including Ontruzant and Aybintio; Bildyos and Bilprevda, a recombinant anti-RANKL human monoclonal antibodies; and Poherdy, a neu receptor antagonist. The company also offers cholesterol-modifying medicines under the Zetia, Ezetrol, Vytorin, Inegy, Atozet, Rosuzet, and Zocor brands; Cozaar and Hyzaar for hypertension; respiratory products to control and prevent asthma symptoms under the Singulair, Dulera, Zenhale, and Asmanex brands, as well as seasonal allergic rhinitis under the Nasonex, Clarinex, and Aerius brands. In addition, it provides dermatology products under the Vtama, Diprosone, and Elocon brand; bone health products under the Fosamax brand; and non-opioid pain management products under the Arcoxia, Diprospan, and Celestone brands, as well as Proscar for symptomatic benign prostatic hyperplasia; and Propecia for male pattern hair loss. The company serves drug wholesalers and retailers, hospitals, clinics, government agencies, health maintenance organizations, pharmacy benefit managers, and other institutions. Organon & Co. was founded in 1923 and is headquartered in Jersey City, New Jersey.

Dividendos repartidos Total últimos 12 meses: 0,0800 USD · Yield: 0,58%
Fecha de pago Importe por participación
14/08/2026 0,0200 USD
11/05/2026 0,0200 USD
23/02/2026 0,0200 USD
20/11/2025 0,0200 USD
15/08/2025 0,0200 USD
12/05/2025 0,0200 USD
24/02/2025 0,2800 USD
12/11/2024 0,2800 USD
16/08/2024 0,2800 USD
10/05/2024 0,2800 USD
23/02/2024 0,2800 USD
10/11/2023 0,2800 USD
17/08/2023 0,2800 USD
12/05/2023 0,2800 USD
24/02/2023 0,2800 USD
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
22/09/2026 13,70 13,72 13,68 13,70 +0,15% 0,29% 1.365.200
21/09/2026 13,70 13,76 13,67 13,68 +0,00% 0,66% 3.116.500
18/09/2026 13,68 13,70 13,68 13,68 -0,07% 0,15% 4.941.500
17/09/2026 13,67 13,69 13,66 13,69 +0,15% 0,22% 1.263.400
16/09/2026 13,65 13,68 13,65 13,67 +0,07% 0,22% 2.072.500
15/09/2026 13,65 13,68 13,65 13,66 +0,07% 0,22% 3.594.100
14/09/2026 13,64 13,67 13,64 13,65 +0,07% 0,22% 1.251.700
11/09/2026 13,65 13,65 13,63 13,64 +0,07% 0,15% 1.728.200
10/09/2026 13,66 13,66 13,63 13,63 -0,29% 0,22% 2.082.200
09/09/2026 13,78 13,78 13,64 13,67 -0,58% 1,05% 5.564.700
08/09/2026 13,77 13,78 13,75 13,75 -0,22% 0,22% 1.629.800
04/09/2026 13,76 13,78 13,76 13,78 +0,07% 0,15% 4.872.500
03/09/2026 13,77 13,78 13,73 13,77 +0,00% 0,40% 3.922.700
02/09/2026 13,77 13,78 13,76 13,77 +0,07% 0,15% 3.626.200
01/09/2026 13,75 13,79 13,75 13,76 +0,00% 0,25% 3.436.900
31/08/2026 13,76 13,77 13,75 13,76 +0,00% 0,15% 4.052.500
28/08/2026 13,76 13,77 13,76 13,76 +0,00% 0,07% 2.708.300
27/08/2026 13,76 13,77 13,76 13,76 -0,07% 0,07% 3.193.700
26/08/2026 13,74 13,77 13,74 13,77 +0,15% 0,22% 4.153.500
25/08/2026 13,74 13,76 13,74 13,75 +0,00% 0,15% 3.562.700
24/08/2026 13,73 13,76 13,72 13,75 +0,00% 0,29% 4.583.400
21/08/2026 13,74 13,76 13,73 13,75 +0,07% 0,22% 1.765.800
20/08/2026 13,70 13,74 13,70 13,74 +0,07% 0,29% 4.045.000
19/08/2026 13,71 13,74 13,69 13,73 +0,37% 0,36% 3.314.100
18/08/2026 13,70 13,72 13,67 13,68 -0,15% 0,40% 2.158.100
17/08/2026 13,71 13,72 13,69 13,70 -0,15% 0,22% 2.317.400
14/08/2026 13,69 13,72 13,69 13,72 +0,00% 0,22% 2.113.300
13/08/2026 13,71 13,72 13,66 13,72 +0,44% 0,44% 2.082.400
12/08/2026 13,65 13,70 13,65 13,66 +0,07% 0,37% 5.606.700
11/08/2026 13,61 13,66 13,61 13,65 +0,22% 0,37% 2.687.900